| Amyloidosis |
1 |
1 |
| Biopsy |
0 |
0.45 |
| Abdomen |
0 |
0.37 |
| Coronary Artery Disease (CAD) |
0 |
0.37 |
| Aminotransferase |
0 |
0.36 |
| Liver |
0 |
0.3 |
| Gastrointestinal Hemorrhage |
0 |
0.28 |
| Liver Failure |
0 |
0.28 |
| Abdominal Pain |
0 |
0.26 |
| Biliary Disease |
0 |
0.24 |
| Ascites |
0 |
0.22 |
| Heart |
0 |
0.22 |
| Heart Failure (HF) |
0 |
0.22 |
| Hospital |
0 |
0.22 |
| Large Intestine |
0 |
0.22 |
| Tissue |
0 |
0.22 |
| Congestive Heart Failure |
0 |
0.21 |
| Cardiometabolic Risk Factors |
0 |
0.2 |
| Hypertension |
0 |
0.18 |
| Artery |
0 |
0.15 |
| Colitis |
0 |
0.15 |
| Colonoscopy |
0 |
0.15 |
| Hemoglobin |
0 |
0.15 |
| Cardiomyopathy |
0 |
0.14 |
| Abdominal Infection |
0 |
0.13 |
| Esophagogastroduodenoscopy (EGD) |
0 |
0.13 |
| Waldenstrom Macroglobulinemia |
0 |
0.13 |
| Renal Failure |
0 |
0.11 |
| Obstructive Sleep Apnea |
0 |
0.1 |
| Primary Bacterial Peritonitis |
0 |
0.1 |
| Waldenstrom Hypergammaglobulinemia |
0 |
0.1 |
| White Blood Cell Count |
0 |
0.1 |
| Bowel Preparation |
0 |
0.09 |
| Inflammatory Bowel Disease |
0 |
0.09 |
| Pain Management |
0 |
0.08 |
| Sleep Apnea |
0 |
0.08 |
| Sleep Disorders |
0 |
0.08 |
| Type 2 Diabetes Mellitus |
0 |
0.08 |
| Amyloid A amyloidosis |
0 |
0.07 |
| Antigens |
0 |
0.07 |
| Autoimmune Disease |
0 |
0.07 |
| Blood |
0 |
0.07 |
| Bone |
0 |
0.07 |
| Cirrhosis |
0 |
0.07 |
| Diabetes Mellitus |
0 |
0.07 |
| Dysphagia |
0 |
0.07 |
| Edema |
0 |
0.07 |
| Encephalopathy |
0 |
0.07 |
| Hemorrhage |
0 |
0.07 |
| Histology |
0 |
0.07 |
| Hyperlipidemia |
0 |
0.07 |
| Hypoalbuminemia |
0 |
0.07 |
| Kidney |
0 |
0.07 |
| Malabsorption |
0 |
0.07 |
| Pain |
0 |
0.07 |
| Paracentesis |
0 |
0.07 |
| Pelvis |
0 |
0.07 |
| Pericardial Effusion |
0 |
0.07 |
| Peritonitis |
0 |
0.07 |
| Plasma |
0 |
0.07 |
| Primary Care |
0 |
0.07 |
| Proteasome Inhibitor |
0 |
0.07 |
| Sleep |
0 |
0.07 |
| Stent |
0 |
0.07 |
| Weakness |
0 |
0.07 |